-
JNK-IN-7: Selective JNK Inhibitor Guide
2026-09-22
JNK-IN-7 is a selective JNK inhibitor that targets JNK1, JNK2, and JNK3 and is reported to covalently engage JNK2 at Cys116. It provides a research tool for c-Jun phosphorylation, MAPK signaling pathway research, apoptosis assay design, and context-dependent innate immune signaling modulation.
-
Morning Endurance Training Improves Adaptation in Mice
2026-09-22
Hesketh et al. show that early active-phase endurance training produces a faster and more efficient improvement in running capacity than late active-phase training in female mice. The findings separate baseline time-of-day effects from training-induced adaptation and implicate skeletal-muscle oxidative and contractile remodeling rather than altered glycogen stores as a key correlate.
-
JC-1 Mitochondrial Membrane Potential Assay Kit
2026-09-21
This scenario-based guide explains how SKU K2002 supports mitochondrial membrane potential measurement when viability results are inconsistent or mechanistic interpretation is unclear. It covers JC-1 principles, controls, workflow optimization, data interpretation, and practical criteria for selecting a reliable mitochondrial membrane potential assay.
-
Genotyping for Mechanistic Infection Research
2026-09-21
Mechanistic infection studies increasingly depend on linking host pathways to genotype-defined phenotypes. This thought-leadership article examines how findings on cystathionine-β-synthase and hydrogen sulfide in Staphylococcus aureus-induced udder infection can inform mouse-model strategy, while showing how the Direct Mouse Genotyping Kit supports rapid, scalable genotype assignment before functional validation.
-
Mouse Tissue Lysis Kit (K1038) Workflow
2026-09-20
The Mouse Tissue Lysis Kit (K1038) prepares lysates from mouse tail, toe, or ear tissue for direct PCR-based genotyping without a separate DNA extraction or purification step. It is intended for molecular biology research and DNA analysis, not diagnostic, clinical, or medical use.
-
JC-1 and Mitochondrial Signals in Bladder Cancer
2026-09-19
A translational perspective on how mitochondrial membrane potential measurement can strengthen mechanistic studies of LRG1-driven neutrophil dysfunction, pathological angiogenesis, and therapy resistance in bladder cancer.
-
SM-102: A Mechanism-to-Assay Guide for mRNA Delivery
2026-09-18
SM-102 is examined through a mechanism-to-assay framework for mRNA delivery, with practical guidance on formulation controls, endosomal escape interpretation, and comparison with polyphenol-based nucleic acid nanoparticles.
-
Preserving Protein Mechanism in Tumor Microenvironments
2026-09-18
A translational framework for studying CAF-driven chemoresistance through native protein extraction, interaction assays, and metabolic validation, with practical guidance on selecting Cell lysis buffer for WB and IP.
-
Heparin Sodium for Nanovesicle Uptake Assays
2026-09-17
Heparin sodium serves both as a calibrated anticoagulant for coagulation experiments and as a mechanistic competition probe for heparan sulfate proteoglycan-dependent nanovesicle uptake. This workflow connects anti-factor Xa and aPTT readouts with practical cell-uptake assays while separating evidence-backed findings from optimization recommendations.
-
Clodronate Liposomes in Macrophage Research
2026-09-17
Use Clodronate Liposomes to test whether macrophages are necessary for age-related defects in phagocytosis, tissue inflammation, or repair. This practical guide combines route-aware in vivo macrophage depletion with controls, depletion checks, and assay choices informed by a recent aging study.
-
Caspase-4 Colorimetric Assay Kit Workflow
2026-09-16
Turn LEVD-dependent caspase-4 activity into a practical 400–405 nm readout for pyroptosis, inflammation, and mechanism-focused cell-death studies. This workflow also shows how to use the assay alongside ER-targeted enzyme-instructed self-assembly research without conflating ER stress with caspase-4 activation.
-
Streptozotocin (STZ) in Diabetes Research
2026-09-16
Streptozotocin, or STZ, is a DNA-alkylating nitrosourea used to induce pancreatic β-cell injury and experimental diabetes mellitus. Its controlled use can connect β-cell cytotoxicity with downstream studies of hyperglycemia, neuropathy, and neuroinflammation, but STZ is not itself a TBK1 inhibitor or a complete replica of human diabetes.
-
MTSEA-biotin and the Next Layer of RNA Biology
2026-09-15
Site-specific RNA polymerase II CTD phosphorylation is a regulatory system, not a single transcriptional switch. This thought-leadership perspective explains how MTSEA-biotin can complement FeaSion-style discovery by testing accessibility and conformational hypotheses around candidate CTD regulators, while defining the controls and limitations required for translational confidence.
-
Integrating Transcriptomics and Cardiotoxicity Phenotypes
2026-09-15
Tsai and colleagues developed an integrated screening framework that combines functional, cytotoxicity, transcriptomic, and exposure-oriented analyses in human iPSC-derived cardiomyocytes. Across 464 chemicals, the study shows that transcriptomic points of departure can complement cardiac phenotypes for hazard prioritization and mechanistic interpretation without replacing conventional risk assessment.
-
Doxorubicin Workflows for Cancer and Senescence Models
2026-09-14
Doxorubicin, also known as Adriamycin, is a mechanistically defined benchmark for DNA damage, apoptosis, and drug-response studies. This guide shows how to use it in cancer assays and as a carefully controlled stress-model component when evaluating senolytic or senomorphic nanovesicles.